BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $614,000 | -1.0% | 4,060 | -4.5% | 0.00% | 0.0% |
| Q2 2022 | $620,000 | -77.4% | 4,253 | -81.6% | 0.00% | -75.0% |
| Q1 2022 | $2,740,000 | +524.1% | 23,108 | +624.8% | 0.00% | +300.0% |
| Q4 2021 | $439,000 | 0.0% | 3,188 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $439,000 | – | 3,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |